Literature DB >> 3903172

Update on cancer chemotherapy: general considerations and breast cancer. Part II.

J C Wright.   

Abstract

An update of the state of the art of chemotherapeutic treatment of the late and early stages of breast cancer is described. Important progress has been made in the control of cancer of the breast since the introduction of effective cancer chemotherapy. Of the common tumors, breast cancer is the most responsive to a wide variety of cancer chemotherapeutic agents.Part I of this article (J Natl Med Assoc 77:8 639-647) reviewed the current use of cancer chemotherapeutic agents in general in the treatment of common types of cancer and the use of hormone therapy in the treatment of breast cancer. Part II describes the use of nonhormonal treatment of breast cancer.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3903172      PMCID: PMC2571169     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN: 0027-9684            Impact factor:   1.798


  50 in total

1.  Clinical studies of triethylenethiophosphoramide in the treatment of inoperable cancer.

Authors:  H SHAY; D C SUN
Journal:  Cancer       Date:  1955 May-Jun       Impact factor: 6.860

2.  Palliation of mammary carcinoma with phosphoramide drugs.

Authors:  J C BATEMAN; H N CARLTON
Journal:  J Am Med Assoc       Date:  1956-10-20

3.  Observations on the effects of the folic acid antagonists, aminopterin and amethopterin, in patients with advanced neoplasms.

Authors:  E B SCHOENBACH; J COLSKY; E M GREENSPAN
Journal:  Cancer       Date:  1952-11       Impact factor: 6.860

4.  An evaluation of folic acid antagonists in adults with neoplastic diseases: a study of 93 patients with incurable neoplasms.

Authors:  J C WRIGHT; A PRIGOT; B WRIGHT; S WEINTRAUB; L T WRIGHT
Journal:  J Natl Med Assoc       Date:  1951-07       Impact factor: 1.798

Review 5.  Single and combination nonhormonal chemotherapy in breast cancer.

Authors:  S K Carter
Journal:  Cancer       Date:  1972-12       Impact factor: 6.860

6.  Cancer of the breast: size of neoplasm and prognosis.

Authors:  B Fisher; N H Slack; I D Bross
Journal:  Cancer       Date:  1969-11       Impact factor: 6.860

7.  Combination cytotoxic chemotherapy in advanced disseminated breast carcinoma.

Authors:  E M Greenspan
Journal:  J Mt Sinai Hosp N Y       Date:  1966 Jan-Feb

8.  Karnofsky Memorial Lecture. Breaking the cure barrier.

Authors:  J F Holland
Journal:  J Clin Oncol       Date:  1983-02       Impact factor: 44.544

9.  Influence of tumor estrogen and progesterone receptor levels on the response to tamoxifen and chemotherapy in primary breast cancer.

Authors:  B Fisher; C Redmond; A Brown; D L Wickerham; N Wolmark; J Allegra; G Escher; M Lippman; E Savlov; J Wittliff
Journal:  J Clin Oncol       Date:  1983-04       Impact factor: 44.544

10.  Sequential continuous infusion with doxorubicin and vinblastine: an effective chemotherapy combination for patients with advanced breast cancer previously treated with cyclophosphamide, methotrexate, 5-FU, vincristine, and prednisone.

Authors:  N Tannir; H Y Yap; G H Hortobagyi; V Hug; A U Buzdar; G R Blumenschein
Journal:  Cancer Treat Rep       Date:  1984 Jul-Aug
View more
  1 in total

1.  Colour Coding Navigation: "Triage" Techniques to Improve Compliance in Breast Cancer Patients Requiring Primary Chemotherapy.

Authors:  Carol Ann Benn; Yastira Ramdas; Barend van den Bergh; Naa-Lamle Bannerman; Dominic van Loggerenberg; Tia van Loggerenberg; Vernon Shaw
Journal:  Eur J Breast Health       Date:  2020-10-01
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.